Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Ngo, Katherine ^a   Kotecha, Dipak ^b   Manzano, Luis ^c   Walters, Julia A E ^d   Flather, Marcus ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BIBLIOGRAPHIC DATABASE; DATA ANALYSIS; DISEASE COURSE; FUNCTIONAL STATUS; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFORMATION PROCESSING; IRON THERAPY; MORTALITY; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; SENSITIVITY ANALYSIS; STROKE; THROMBOEMBOLISM; TREADMILL EXERCISE; TREATMENT RESPONSE;

EID: 70249101727     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007613     Document Type: Review

References (23)

1. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, et al.Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. Journal of the American College of Cardiology 2001;38(4):955-962 (Pubitemid 32912694)
2. Anand IS. Heart failure and anemia: mechanisms and pathophysiology. Heart Failure Review 2008;13:379-386
3. Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, et al.Venous thromboembolismandmortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008;299(8):914-924
4. Blanc B, Finch CA, Hallberg L. Nutritional Anaemias: Report of a WHO Scientific Group. World Health Organisation Technical Report Series 495. Geneva: World Health Organization, 1968:5-37.
5. Cleland JG, Khand AU, Clark AL. The heart failure epidemic: exactly how big is it?. European Heart Journal 2001;22(8):623-626 (Pubitemid 32622421)
6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-188
7. EggerM, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634 (Pubitemid 27387172)
8. Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. Journal of the American College of Cardiology 2004;44:959-966 (Pubitemid 39165127)
9. Henke M, Laszig R, Rube C, Schafer U, Haase K D, Schilcher B, et al.Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362(9392):1255-1260 (Pubitemid 37324251)
10. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
11. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008.
12. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. Journal of the American College of Cardiology 2002;39(11):1780-1786 (Pubitemid 34595288)
13. Hunt SA. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Journal of the AmericanCollege of Cardiology 2005;46(6):e1-82.
14. KDOQI, National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. American Journal of Kidney Disease 2006; 47(5 Suppl 3):S11-145.
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719-748
16. Mitchell JE. Emerging Role of Anemia in Heart Failure. American Journal of Cardiology 2007;99(6 Supplement 2):S15-20.
17. Parsa CJ, Kim J, Riel RU, Pascal LS, Thompson RB, Petrofski JA, et al.Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. Journal of Biological Chemistry 2004;279(20):20655-20662 (Pubitemid 38656460)
18. Peeters HR, Jongen-Lavrencic M, Vreugdenhil G, Swaak AJ. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Annals of Rheumatic Diseases 1996;55(10):739-744 (Pubitemid 26354435)
19. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146. (Pubitemid 43754289)
20. Shord SS, Hamilton Jr JM, Cuellar S. Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia. Journal of Oncology Pharmacy Practice 2008;14:5-22.
21. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al.Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. European Heart Journal 2005;26(11):1115-1140
22. Weiss G, Goodnough LT. Anemia of Chronic Disease. New England Journal of Medicine 2005;352(10):1011-1023
23. Westenbrink BD, Lipsic E, van derMeer P, van derHarst P, Oeseburg H, Du Marchie Sarvaas GJ, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. European Heart Journal 2007;28(16):2018-2027